As many as 1 in 5 people wont lose weight with GLP-1 drugs, experts say As many as 1 in 5 people wont lose weight with GLP-1 drugs, experts say Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them
Similarly, patients with obesity and metabolic syndrome often exhibit chronic low-grade inflammation, and GLP-1 receptor agonists approved for weight management may address both adiposity and inflammatory burden simultaneously
GLP-1, or Glucagon-Like Peptide-1, is a naturally occurring hormone that regulates blood sugar levels and appetite
To learn more, visit Primes clinical insights on MASH
Trulicity (dulaglutide): Possible side effects include fatigue, GI symptoms and decreased appetite
The report notes the presence of counterfeit Ozempic, the use of non-FDA-approved ingredients such as retatrutide or cagrilintide, and products bypassing regulations by being labeled as not for human consumption. As of July 2024 the most recently issued report the FDA had received over 1,000 reports of adverse events related to compounded semaglutide and compounded tirzepatide
